![](/img/cover-not-exists.png)
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
Mattsson, Niklas, Lönneborg, Anders, Boccardi, Marina, Blennow, Kaj, Hansson, OskarVolume:
52
Language:
english
Journal:
Neurobiology of Aging
DOI:
10.1016/j.neurobiolaging.2016.02.034
Date:
April, 2017
File:
PDF, 1.05 MB
english, 2017